The European Commission has granted Eli Lilly & Co. marketing rights for Olumiant, a drug used to treat patients suffering with severe rheumatoid arthritis. Read More »

Recently passed legislation now allows Medicare to pay pharmacists for services provided to beneficiaries in underserved communities. Read More »

The Centers for Disease Control and Prevention has releases detailed information on the risks that flu season presents.  Read More »

The Department of Veterans Affairs is looking to expand pharmacists’ roles as health care providers for veterans living in rural communities.  Read More »

The Missoula Urban Indian Health Center is participating in offering education, care coordination and patient-navigator services to more than 30 Indian tribes.  Read More »

Biotech company Amgen submitted an application to the U.S. Food and Drug Administration for Blincyto, a drug used in the treatment of lymphoblastic leukemia, to broaden its uses and treatments. Read More »

Global pharmaceutical maker Mylan will host Investor Day on March 1 in New York City. Read More »

Newly released data published in the Multiple Sclerosis Journal shows Cladribine tablets significantly reduce brain atrophy in patients suffering with multiple sclerosis. Read More »

GSK Consumer Healthcare has launched Flonase Allergy Relief for the treatment of seasonal allergies. Read More »

Medical business management service provider Medac Inc. has completed a Service Organization Control 2 certification. Read More »

The Lower Drug Costs through Competition Act created by the House Energy and Commerce Committee was taken off the committee’s fast track on Feb. 3 Read More »

McKesson Health Solutions, a company that specializes in helping patients with medical payments, recently announced its new analytics system HealthQx received certification in the Prometheus Analytics model. Read More »

Teva Pharmaceutical Industries' chairman Yitzhak Peterburg has been appointed interim president and chief executive officer. Read More »

Global pharmaceutical leader Allergan is launch a new campaign to bring awareness to blindness, and commit to fighting preventable blindness in the United States in its new See America initiative. Read More »

The U.S. Food and Drug Administration has approved deflazacort, a new treatment for Duchenne muscular dystrophy in patients 5 years and older. Read More »

The U.S. Food and Drug Association is reviewing AbbieVie's New Drug Application (NDA) for a new treatment of Hepatitis C virus.  Read More »

The U.S. Federal Trade Commission has filed a civil action suit against a subsidiary of Shire, PLC, as part of a citizen petition submission regarding antibiotic Vancocin. Read More »

The recent 2017 Economic Report on Pharmacies and Pharmacy Benefit Managers by Drug Channels named the top 15 U.S. Pharmacies of 2016.  Read More »

Allergan has made a substantial donation to the American Association for the Study of Liver Diseases Foundation, becoming part of AASLD’s Founder’s Society. Read More »

Acorda Therapeutics' CVT-301, a drug used in treating people with Parkinson’s disease, showed significant improvement in motor functions during a Phase 3 clinical trial. Read More »